Fundamental Applied Biology Inc., a Menlo Park, Calif.– based developer of protein therapeutics, has called down $4.77 million of a $21.48 million Series B round, according to a regulatory filing. Alta Partners was joined by return backer SV Life Sciences. www.f-a-b-inc.com
If you do not receive this within five minutes, please try and sign in again. If the problem persists, please
email: subscriptions@peimedia.com.